Welcome to Stock Trading Signals

Daily Top Stocks Pick Alert

Hottest Stocks in 2015- ANAC- ZIOP -ADXS- EXEL
Hottest Penny Stocks in 2015 - CTRV -HLTH-FRO
Stocks Pick in 2015 - AAPL - BAC - ANR - X
Hottest Stocks in 2014- AVNR- AGIO -ACH- VDSI
Hottest Penny Stocks in 2014 - JOB -PLUG-QTM
My Daily Trading Activities - Membership Link

Tuesday, November 4, 2014

Pre-Market Biggest Stock Gainers & Losers -11/4/14

During premarket trading hours, there were many stocks that continued to break up to the upside.These stocks are usually going up or down on with news.If you are looking to day trade today, you might want to check out the following stocks. I usually throw these on my watch list and monitor with resistance & support levels. Below are a list of stocks that I am watching for today.You can also check previous stocks to buy reports- Right Here  

Premarket Gainers / Losers

Top #PreMarket Gainers

Office Depot (NASDAQ: ODP) shares jumped 12.43% to $5.70 in pre-market trading after the company reported better-than-expected Q3 earnings.

Theravance Biopharma (NASDAQ: TBPH) shares gained 7.62% to $19.50 in the pre-market trading session after the company reported positive results from Phase 1 proof-of-concept study of TD-6450, an NS5A Inhibitor to treat Hepatitis C.

CVS Health (NYSE: CVS [FREE Stock Trend Analysis]) shares surged 3.05% to $88.75 in pre-market trading after the company reported upbeat Q3 earnings.

Becton, Dickinson and Co (NYSE: BDX) shares rose 2.02% to $130.00 in pre-market trading after the company reported better-than-expected profit for the fourth quarter.

Top #PreMarket Losers:
  
RetailMeNot (NASDAQ: SALE) fell 23.04% to $15.70 in pre-market trading after the company issued a weak Q4 revenue forecast and appointed Louis Agnese as interim CFO.

Herbalife (NYSE: HLF ) shares slipped 13.24% to $48.50 in pre-market trading after the company reported weaker-than-expected third-quarter earnings and lowered its full-year outlook.

Sprint (NYSE: S) shares dropped 12.58% to $5.42 in pre-market trading after the company posted a wider-than expected second-quarter loss and warned of higher costs in the current period. The company announced its plans to cut its work force by an additional 2,000 positions

Regeneron Pharmaceuticals (NASDAQ: REGN) shares declined 6.42% to $369.90 in pre-market trading after the company reported weaker-than-expected Q3 earnings.

For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com